Episode
Merck Eyes Global Approval, Prisoners Dilemma Cooperation Emerges, HistoSonics Wins Asia Approval, AI Maps Autism and ADHD Paths, and more...
- Podcast
- Science News Daily
- Published
- May 19, 2026
- Duration seconds
- 628
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/8cfb0f37
Actions
POST https://stenobird.com/v1/public/podcasts/science-news-daily-6698943/episodes/merck-eyes-global-approval-prisoners-dilemma-cooperation-emerges-histosonics-wins-asia-approval-ai-maps-autism-and-adhd-paths-and-more/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/science-news-daily-6698943/merck-eyes-global-approval-prisoners-dilemma-cooperation-emerges-histosonics-wins-asia-approval-ai-maps-autism-and-adhd-paths-and-more.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
(0:10): Sacituzumab Tirumotecan Boosts Survival in Endometrial Cancer; Merck Eyes Global Approval (2:21): Rutgers Study Reveals Natural Pathways to Cooperation in Prisoner's Dilemma Without Kinship or Rules (3:40): HistoSonics Gains Ground in Asia with TFDA Approval for Edison Histotripsy System (5:24): Swedish Study Expands to Predict Autism, ADHD Trajectories with AI by Age 10 (7:54): GlucoBrain: Revolutionizing Diabetes-Dementia Research with 3D Microfluidic Biochip To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: Rutgers University